AvePoint (NASDAQ:AVPT) Stock: Insider Brian Michael Brown Sells 10,000 Shares

AvePoint, Inc. (NASDAQ:AVPT - Get Free Report) insider Brian Brown sold 10,000 shares of the stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $13.07, for a total transaction of $130,700.00. Following the sale, the insider owned 374,604 shares of the company's stock, valued at $4,896,074.28. This trade represents a 2.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Brian Michael Brown also recently made the following trade(s):

• On Thursday, August 27th, Brian Brown sold 60,000 shares of AvePoint stock. The shares were sold at an average price of $14.20, for a total transaction of $852,000.00.
• On Monday, August 24th, Brian Brown sold 10,000 shares of AvePoint stock. The stock was sold at an average price of $13.30, for a total transaction of $133,000.00.
• On Wednesday, July 29th, Brian Brown sold 5,176 shares of AvePoint stock. The shares were sold at an average price of $13.06, for a total transaction of $67,598.56.
• On Tuesday, July 28th, Brian Brown sold 4,824 shares of AvePoint stock. The shares were sold at an average price of $13.08, for a total transaction of $63,097.92.

AvePoint Price Performance

---

---

NASDAQ AVPT opened at $13.00 on Friday. The stock's 50 day simple moving average is $13.18 and its 200 day simple moving average is $11.48. AvePoint, Inc. has a one year low of $8.84 and a one year high of $15.58. The firm has a market cap of $2.75 billion, a PE ratio of 40.63 and a beta of 1.19.

AvePoint (NASDAQ:AVPT - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.04. The firm had revenue of $124.50 million during the quarter, compared to the consensus estimate of $121.38 million. AvePoint had a return on equity of 15.97% and a net margin of 15.33%. As a group, equities analysts expect that AvePoint, Inc. will post 0.25 earnings per share for the current year.

Analysts Set New Price Targets

AVPT has been the topic of several research reports. DA Davidson reiterated a "buy" rating and set a $18.00 price target on shares of AvePoint in a research report on Monday, July 6th. TD Cowen boosted their target price on shares of AvePoint from $14.00 to $15.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Evercore reiterated an "outperform" rating and set a $16.00 target price on shares of AvePoint in a research report on Friday, August 7th. Wall Street Zen raised shares of AvePoint from a "hold" rating to a "buy" rating in a research note on Saturday, September 12th. Finally, Scotiabank raised their price target on shares of AvePoint from $12.00 to $15.00 and gave the company a "sector outperform" rating in a report on Friday, August 7th. Ten analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $16.36.

Read Our Latest Research Report on AvePoint

Institutional Trading of AvePoint

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its holdings in AvePoint by 25.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,264,082 shares of the company's stock worth $31,040,000 after purchasing an additional 666,422 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of AvePoint by 106.7% in the 2nd quarter. Wellington Management Group LLP now owns 2,776,579 shares of the company's stock valued at $31,125,000 after purchasing an additional 1,433,299 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of AvePoint by 25.0% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,675,587 shares of the company's stock worth $25,445,000 after buying an additional 535,015 shares during the period. Renaissance Technologies LLC grew its position in shares of AvePoint by 16.4% during the 1st quarter. Renaissance Technologies LLC now owns 2,580,153 shares of the company's stock worth $24,537,000 after buying an additional 363,200 shares during the period. Finally, SG Americas Securities LLC grew its position in shares of AvePoint by 335.2% during the 1st quarter. SG Americas Securities LLC now owns 2,391,696 shares of the company's stock worth $22,745,000 after buying an additional 1,842,124 shares during the period. 44.49% of the stock is currently owned by institutional investors and hedge funds.

About AvePoint

(Get Free Report)

AvePoint, Inc provides data management, governance, protection and migration software for organizations using cloud collaboration and productivity platforms. Its solutions are designed to help businesses, government agencies and educational institutions manage data throughout its lifecycle, improve security and compliance, and support digital transformation initiatives.

The company's product portfolio supports platforms including Microsoft 365, Microsoft Dynamics 365, Salesforce and Google Workspace.

See Also

• Five stocks we like better than AvePoint
• Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
• Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
• Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
• Oil May Be Stronger Than It Looks—And Diamondback Is on Sale

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].